Medbright AI Investments Inc (MBAIF)

[StockInfo11]

MBAI is trading in the green on above-average volume after announcing that it is expanding its MedMatrix AI-Health-Tech Platform's collaboration with Rejuvenation, a leading dermatology group. The move enhances cosmetic marketing and clinical trial analytics, elevating patient care and solidifying MedBright's role in healthcare technology investments
https://financialpost.com/globe-newswire/medbright-ais-medmatrix-to-expand-its-ai-offerings-for-cosmetic-marketing-clinical-trial-analytics

This expansion highlights the scalability of MBAI's MedMatrix Platform within the massive 200 billion dollar addressable healthcare market. It also highlights the ability for MBAI to scale the deployment and number of users of their Medmatrix platform rapidly. Despite MBAI's Market Cap being less than 22M they have already signed on 14 clinics within 2 months, (including a Yale School of Medicine Affiliated Clinic Group).

The scalability of this tech and the size of the addressable market means easy multiples here if they can continue to execute on signing up clinics.